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The humanT cell compartment is a complex system and while some information is known
on repertoire composition and dynamics in the peripheral blood, little is known about reper-
toire composition at different anatomical sites. Here, we determine theT cell receptor beta
variable (TRBV) repertoire at the decidua and compare it with the peripheral blood during
normal pregnancy and pre-eclampsia. We found total T cell subset disparity of up to 58%
between sites, including large signature TRBV expansions unique to the fetal–maternal
interface. Defining the functional nature and specificity of compartment-specific T cells
will be necessary if we are to understand localized immunity, tolerance, and pathogenesis.
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INTRODUCTION
αβ T cells recognize antigens via the heterodimeric T cell recep-
tor (TR), which is comprised of one alpha (TRA) chain and
one beta (TRB) chain. The αβ TR is the most diverse protein
in humans with the V(D)J recombination machinery producing
2.5× 106 unique TR structures from a theoretical catalog of 1020
structures [reviewed in Ref. (1)]. This hugely diverse base reper-
toire enables broad recognition of millions of self and foreign
antigens.
The T cell repertoire can be defined by quantifying the expres-
sion of different T cell receptor beta variable (TRBV) proteins on
the cell surface or from intracellular transcripts (1). Using this
method, repertoire differences between blood and other anatom-
ical sites can be investigated. For instance, large differences in
T cell repertoire profile have been observed between periph-
eral blood mononuclear cells (PBMC) and colon tissue (2), with
colon-resident T cells expressing a much more restricted TRBV
signature (3). Compartment-specific T cell repertoires have also
been noted at the fetal–maternal interface (4). This site is anatomi-
cally known as the decidua and only global TRBV usage in decidual
mononuclear cells (DMC) have been examined to date. Multivari-
ate dissection is important given that large clonal expansions are
generally concentrated within the CD8+ (5) and regulatory T cell
(Treg) (6) subsets.
Tregs play a defining role in pregnancy, overseeing maternal
tolerance of the semi-allogeneic fetus (7). It has been shown
that a significantly higher proportion of Tregs is present in the
decidua compared with PBMC (8). In cases of pre-eclampsia
and spontaneous abortion, this percentage is significantly reduced
(9), emphasizing the critical role of Tregs in the maintenance of
pregnancy.
Given that we know very little of the composition of T cell
repertoires operating at decidua, we undertook immunoprofiling
to define TR usage at the fetal–maternal interface within different
T cell lineages. Using multiparametric flow cytometry-based phe-
notyping and TRBV dissection, we assessed the DMC repertoires
of CD8+ CD4+ and Treg cells from women with healthy preg-
nancies and pre-eclampsia and compared these repertoires with
corresponding subsets in peripheral blood.
MATERIALS AND METHODS
PATIENTS
Five term healthy pregnant women and three pre-eclamptic
women in the third trimester of pregnancy from Nepean Hos-
pital (Sydney, NSW, Australia) were included in this study. Pre-
eclampsia was defined according to the International Society for
the Study of Hypertension in Pregnancy criteria as onset of high
blood pressure (>140/90) and proteinuria (>0.3 g/24 h) after
20 weeks of gestation (10). Patient details can be found in Table A2
in Appendix. Patients with diabetes, infectious conditions, chro-
mosomal abnormalities, and/or morphological anomalies were
excluded. This study was approved by the Human Research Ethics
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Committee of the Nepean Blue Mountains Local Health District,
Penrith, NSW, Australia.
MONONUCLEAR CELL ISOLATION
DMC were obtained as previously described (11, 12). Briefly,
decidua basalis was carefully dissected from the maternal surface of
freshly delivered placenta. This was washed with PBS until the elu-
ent was macroscopically clear of blood. The tissue was then minced
by a pair of fine scissors to 1–2 mm pieces. A cocktail of collagenase
(300 U/ml), hyaluronidase (2 mg/ml), DNase (50µg/ml) (Sigma-
Aldrich) added to RPMI-1640 containing 2 mM l-Glutamine,
100 U/ml penicillin, 100µg/ml streptomycin, and 5% fetal calf
serum was used for enzymatic digestion of decidual tissue. 10 ml
of this mixture was used per 1 g of wet tissue weight, incubated
at 37°C with gentle rotation. A regimen of 3× 20 min pulsed
digestion followed by 1 h digestion was performed. At the end
of each period of digestion, supernatant containing released cells
was removed. This was then washed once in PBS. At the end
of the digestion, all washed supernatants were combined and
filtered through a 70-µm sieve. Mononuclear cells were subse-
quently isolated using Ficoll–Hypaque (Amersham Pharmacia)
density gradient centrifugation. DMC were then isolated using
density gradient centrifugation over Ficoll–Hypaque. All samples
were cryopreserved in RPMI-1640 containing 20% fetal bovine
serum and 10% dimethyl sulfoxide (Sigma-Aldrich) and stored in
liquid nitrogen.
T CELL REPERTOIRE IMMUNOPROFILING
Thawed PBMC or DMC were incubated for 30 min at 4°C with
live/dead fixable aqua dead cell stain (Life Technologies), CD4
Alexa Fluor 700, CD8 Cy5.5-PerCP, and CD25 Cy7-phycoerythrin
(BioLegend). Each sample was then divided and labeled for 30 min
at 4°C with 1 of 25 phycoerythrin- or fluorescein isothiocyanate-
labeled TRBV-specific mAb (Table A1 in Appendix). Nomen-
clature used in this study is based on IMGT®, the interna-
tional ImMunoGeneTics information system®, http://www.imgt.
org (13). Functional TRBV genes (14) not covered by this panel
include; TRBV5-4, TRBV5-8, TRBV6-1, TRBV6-2, TRBV6-3,
TRBV6-4, TRBV6-8, TRBV7-3, TRBV7-4, TRBV7-6, TRBV7-7,
TRBV7-8, TRBV7-9, TRBV10-1, TRBV10-2, TRBV11-1, TRBV11-
3, TRBV12-5, TRBV15, TRBV16, TRBV24-1, and TRBV29-1. After
washing with PBS, the FoxP3 Fix/Perm Buffer Set and FoxP3 Alexa
Fluor 647 mAb (BioLegend) were used to label intracellular FoxP3,
according to the manufacturer’s protocol. Cells were analyzed on a
FACSCanto II flow cytometer using FACSDiva software (BD Bio-
sciences). Flow cytometry data were analyzed and presented using
FlowJo software (TreeStar). A representative example of cell gating
can be found in Data Sheet 2 in Supplementary Material.
RESULTS AND DISCUSSION
Five term healthy pregnant women and three pre-eclamptic
women were enrolled in the study. Blood was drawn prior to deliv-
ery and PBMC isolated by density gradient centrifugation. DMC
were obtained from freshly delivered placenta by tissue diges-
tion and density gradient centrifugation as described in Section
“Materials and Methods.” To compare the TRBV repertoires of
different T cell subsets at each site, we employed mutiparamet-
ric flow cytometry and intracellular staining. Here, a panel of
TRBV-specific mAb was combined with the phenotypic makers
CD8, CD4, forkhead box P3 (FoxP3), and CD25 to dissect out TR
repertoires of CD8+, CD4+, and Treg (CD4+ FoxP3+ CD25+)
subsets. Although the antibody panel did not cover all TRBV gene
products, TRBV profiling identified an average of 61% of the pop-
ulation for CD8+ T cells, 71% for CD4+ T cells, and 83% for
Tregs (data not shown). The frequency of each TRBV subgroup as
a percentage of the identified repertoire was calculated for each
T cell subset. Frequencies were then compared between DMC
and PBMC to determine the absolute difference in frequency for
each TRBV subgroup within each T cell subset (Data Sheet 1 in
Supplementary Material).
We observed variation in TRBV usage between DMC and
PBMC across all donors and across all T cell subsets (Figure 1).
However, the degree of variation was clearly partitioned by T cell
subset. CD4+ T cells showed the least disparity between anatomi-
cal sites with TRBV subgroups exhibiting<5% absolute variation
in all cases but one. Interestingly, across both cohorts, the total
CD4 compartment was surprisingly stable between the DMC
and PBMC. Intriguingly, this repertoire stability included promi-
nent TRBV5-1, TRBV19, and TRBV20 populations even between
genetically diverse mothers (Data Sheet 1 in Supplementary
Material).
In contrast with the CD4+ subset, CD8+ and Treg subsets
exhibited considerable TR variation between anatomical sites.
Between DMC and PBMC, CD8+ repertoire variation was strik-
ing with absolute differences in single TRBV subgroups up to 28%
of the total compartment (Figure 1). For example, in donor H3,
one in three CD8+ T cells in the DMC bore a receptor expressing
TRBV27. This TRBV frequency at the decidua was more than
threefold higher than peripheral blood (Data Sheet 1 in Sup-
plementary Material). Interestingly, TRBV27 enrichment within
DMC was also noted in donor H1. However, consistent TRBV27
enrichment was not seen across all donors precluding designa-
tion of this subgroup as an immunological fixture at the decidua
in non-related humans. Other notable TRBV deviations between
CD8+ compartments included a large TRBV9 expansion in the
peripheral blood of donor H4. This population comprised 38% of
the total CD8+ cells in PBMC, compared with 10% of total cells
at the DMC (Data Sheet 1 in Supplementary Material). Further
DMC-specific enrichment was observed for TRBV9 in donor H5
and pre-eclampsia donor P2 that was up to twofold higher than in
peripheral blood (Data Sheet 1 in Supplementary Material).
Akin to the CD8+ subset, the Treg subset also exhibited con-
siderable TR variation between DMC and PBMC with absolute
differences of single TRBV subgroups up to 15% of the total com-
partment. Also of note, all donors except H5 exhibited a >5%
absolute deviation in one or more TRBV subgroups between
compartments. Notable DMC-specific enrichments included a
dominant TRBV9 expansion in donor H2 that was 3.5-fold
higher than in peripheral blood (Data Sheet 1 in Supplemen-
tary Material). Additionally, the TRBV4 subgroup represented by
the identification of TRBV4-1, TRBV4-2, TRBV4-3 was clearly
enriched in the DMC of donor H1 and TRBV5-1 was enriched
in the DMC of both donor H4 and pre-eclampsia donor P3
(Data Sheet 1 in Supplementary Material). One curious obser-
vation in the Treg subset was the dominance of the TRBV20-1
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FIGURE 1 | Absolute differences between DMC and PBMCTRBV
subgroup usage for eachT cell subset. For each patient, the percentage of
the identified repertoire represented by each TRBV subgroup in DMC subsets
was compared with that of T cell subsets within PBMC. These absolute
differences in TRBV frequency between PBMC and DMC are shown for each
donor, within (A) CD8+T cells, (B) CD4+T cells, and (C) Treg cells. Genes
encoding TRBV for which no antibody was included or available are indicated
by a #. TRBV gene names are according to the IMGT nomenclature (13, 14).
*Although clone IMMU 222 has previously thought to recognize TRBV6-6, in
addition to TRBV6-5 and TRBV6-9 (15), our data suggest that IMMU 222 is not
TRBV6-6-specific, as dual staining was not observed using both IMMU 222
and JU74.3 mAbs.
gene across all examined donors (Data Sheet 1 in Supplementary
Material). In both PBMC and DMC compartments, TRBV20-1
positive T cells were extremely common representing 11–24%
of the total Treg repertoire. Interestingly, we recently observed
this TRBV20-1 immunodominance in Treg using an alternate
immunoprofiling method of high throughput TR sequencing
(16). Here, TRBV20-1 was used extensively by Tregs [29.5% of
the sequences assigned to clonotypes defined as IMGT clono-
types (AA) (16)], but less by the CD8+ and CD4+ repertoires
(20 and 16%, respectively). Across all subsets, TRBV20-1 repre-
sented 21.9% of all functional clonotypes. Additionally, another
high throughput TR sequencing study using pooled PBMC from
500 individuals revealed that TRBV20-1 was commonly used
(average 24.6% of total TRBV genes) (17). These common obser-
vations tentatively suggest that there is something fundamen-
tal about the TRBV20-1 gene in T cell and Treg ontogeny and
function.
To determine the overall disparity between TRBV repertoires
of PBMC and DMC from each patient, the sum of the absolute
differences in frequency for each TRBV subgroup was calculated
(Figure 2). The mean sum of absolute differences was 17% for
CD4+ T cells (range 11–29%), 41% for CD8+ T cells (range 25–
58%), and 45% for Tregs (range 35–57%). The sum of absolute
differences was compared between healthy pregnant donors and
patients with pre-eclampsia, and no significant differences were
identified for the three T cell subsets assessed (Student’s t -test).
While no difference in global repertoire was observed between
healthy pregnancy and pre-eclampsia, it will be important for
future studies to determine clonotypic usage of these subsets
during health and disease.
The idea that TRBV repertoire is partitioned by anatomical site
was proposed by Ochsenreither et al., who compared T cells from
healthy colon tissue and colorectal carcinoma with PBMC from
the same donor (3). They found that the TR repertoire differed
between sites, with the mucosal cells being more limited in TRBV
diversity. The authors proposed that colon-specific antigens were
responsible for shaping the local T cell repertoire. Our data sim-
ilarly suggest that exposure of T cells to unique antigens in the
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FIGURE 2 | Sum of absolute differences betweenTRBV usage of CD8+,
CD4+, andTreg subsets in DMC and PBMC. For each patient, the
percentage of the identified repertoire represented by each TRBV subgroup
in DMC subsets was compared with that of T cell subsets within PBMC.
The sum of the absolute differences in TRBV frequency for all 25 subgroups
analyzed was calculated, for each T cell subset, to determine the total
difference between repertoires of T cells from DMC and PBMC. No
significant difference (NS) was found between healthy and pre-eclamptic
patients, for any T cell subset (Student’s t -test).
decidua could be underlying the variation seen between T cell
repertoires in these two compartments.
Within the decidual Treg population, it is likely that expanded
TRBV subgroups are critical for maternal tolerance of the fetus.
Identifying the antigen specificity of cells within these subgroups
would help clarify their functional role within the decidua. Given
the prominent differences between T cell subset repertoires of the
PBMC and DMC, further investigation is warranted. Comprehen-
sive clonotypic characterization across T cell subsets is the logical
next step, ideally using unbiased high throughput TR sequenc-
ing technology (16). Studies such as these will help categorize the
newly classified tissue resident T cell subsets (18) and may assist
in understanding the TRBV20 enrichment in Treg. They may also
identify subsets of “innate like”αβT cells that are known to engage
an emerging suite of non-classical major histocompatibility (MH)
proteins (19).
Although healthy donors and patients with pre-eclampsia
exhibited the same level of variation in TRBV repertoire between
the two compartments, this study does not rule out that the
decidual Treg population in pre-eclamptic patients lacks essen-
tial clonotypes required for maternal tolerance. Previous studies
have shown that number (8) and phenotypic composition (20) of
decidual Tregs differ between healthy and pre-eclamptic pregnan-
cies, but clonotypic diversity is yet to be comprehensively assessed.
These studies will be important since it is known that the “type”
of clonotype chosen by the host can determine clinical outcome
across many disease states (1).
In summary, we have shown that T cell repertoires within
decidual tissue differ substantially from those in peripheral blood,
particularly in the CD8+ and Treg subsets. Further study of
expanded TRBV subgroups within decidual tissue, and Tregs in
healthy pregnant donors and pre-eclampsia patients could pro-
vide critical insights into the mechanisms of maternal tolerance
and the etiology of pre-eclampsia.
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APPENDIX
Table A1 | Monoclonal antibody characteristics.
Reagent antibody TRBV gene specificityd Clone name Fluorochrome Catalog numbera
Vbeta 1 TRBV9 BL37.2 FITC MCA1591Fc
Vbeta 2 TRBV20-1 MPB2D5 PE IM2213
Vbeta 3 TRBV28 CH92 FITC IM2372
Vbeta 4 TRBV29-1 WJF24 PE IM3602
Vbeta 5.1 TRBV5-1 IMMU 157 PE IM2285
Vbeta 5.2 TRBV5-6 36213 PE IM2286
Vbeta 5.3 TRBV5-5 3D11 PE IM2002
Vbeta 6.7 TRBV7-2 OT145 FITC TCR2657b
Vbeta 7.1 TRBV4-1, TRBV4-2, TRBV4-3 ZOE PE IM2287
Vbeta 7.2 TRBV4-3 ZIZOU4 PE IM3604
Vbeta 8 TRBV12-3, TRBV12-4 56C5.2 PE IM2289
Vbeta 9 TRBV3-1 FIN9 PE IM2003
Vbeta 11 TRBV25-1 C21 PE IM2290
Vbeta 12 TRBV10-3 VER2.32.1 PE IM2291
Vbeta 13.1 TRBV6-5, TRBV6-6e, TRBV6-9 IMMU 222 PE IM2292
Vbeta 13.2 TRBV6-2, TRBV6-3 H132 PE IM3603
Vbeta 13.6 TRBV6-6 JU74.3 FITC IM1330
Vbeta 14 TRBV27 CAS1.1.3 PE IM2047
Vbeta 16 TRBV14 TAMAYA1.2 FITC IM1560
Vbeta 17 TRBV19 E17.5F3.15.13 PE IM2048
Vbeta 18 TRBV18 BA62.6 PE IM2049
Vbeta 20 TRBV30 ELL1.4 PE IM2295
Vbeta 21.3 TRBV11-2 IG125 FITC IM1483
Vbeta 22 TRBV2 IMMU 546 PE IM2051
Vbeta 23 TRBV13 AF23 PE IM2004
aTRBV mAb sourced from Beckman Coulter unless specified.
bPierce endogen.
cSerotec.
dTRBV gene specificity is from IMGT®, http:// www.imgt.org, IMGT repertoire (IG and TR)>6. Gene regulation and expression> reagents monoclonal antibodies’
(13, 14), except for IM3602 and IM3604 (not published).
eIMMU 222 may not be TRBV6-6-specific (see Data Sheet 1 in Supplementary Material).
Table A2 | Patient characteristics.
Healthy pregnancy Pre-eclampsia
Sample numbers 5 3
Age (years) 28.0 (±2.7) 28.3 (±5.2)
Gestational age at delivery (weeks) 38.8 (±0.35) 36.9 (±1.5)
Birth weight (grams) 3480 (±354) 2996 (±512)
Numbers shown represent means (±standard deviations).
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